These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 15845650)
1. Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways. Huh JE; Lee EO; Kim MS; Kang KS; Kim CH; Cha BC; Surh YJ; Kim SH Carcinogenesis; 2005 Aug; 26(8):1436-45. PubMed ID: 15845650 [TBL] [Abstract][Full Text] [Related]
2. 1,2,3,4,6-Penta-O-galloly-beta-D-glucose suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1α and signaling in LNCaP prostate cancer cells. Park KY; Lee HJ; Jeong SJ; Lee HJ; Kim HS; Kim SH; Lim S; Kim HC; Lü J; Kim SH Biol Pharm Bull; 2010; 33(11):1835-40. PubMed ID: 21048308 [TBL] [Abstract][Full Text] [Related]
3. Compound K inhibits basic fibroblast growth factor-induced angiogenesis via regulation of p38 mitogen activated protein kinase and AKT in human umbilical vein endothelial cells. Jeong A; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Bae H; Kim SH Biol Pharm Bull; 2010; 33(6):945-50. PubMed ID: 20522957 [TBL] [Abstract][Full Text] [Related]
4. Oral administration of penta-O-galloyl-β-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition. Lee HJ; Seo NJ; Jeong SJ; Park Y; Jung DB; Koh W; Lee HJ; Lee EO; Ahn KS; Ahn KS; Lü J; Kim SH Carcinogenesis; 2011 Jun; 32(6):804-11. PubMed ID: 21289371 [TBL] [Abstract][Full Text] [Related]
5. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060 [TBL] [Abstract][Full Text] [Related]
6. Glyceollins, a novel class of soy phytoalexins, inhibit angiogenesis by blocking the VEGF and bFGF signaling pathways. Lee SH; Lee J; Jung MH; Lee YM Mol Nutr Food Res; 2013 Feb; 57(2):225-34. PubMed ID: 23229497 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 activity by 1,2,3,4,6-penta-O-galloyl-beta-D-glucose in murine macrophage cells. Lee SJ; Lee IS; Mar W Arch Pharm Res; 2003 Oct; 26(10):832-9. PubMed ID: 14609132 [TBL] [Abstract][Full Text] [Related]
8. Melittin suppresses VEGF-A-induced tumor growth by blocking VEGFR-2 and the COX-2-mediated MAPK signaling pathway. Huh JE; Kang JW; Nam D; Baek YH; Choi DY; Park DS; Lee JD J Nat Prod; 2012 Nov; 75(11):1922-9. PubMed ID: 23110475 [TBL] [Abstract][Full Text] [Related]
10. An oriental herbal cocktail, ka-mi-kae-kyuk-tang, exerts anti-cancer activities by targeting angiogenesis, apoptosis and metastasis. Lee HJ; Lee EO; Rhee YH; Ahn KS; Li GX; Jiang C; Lü J; Kim SH Carcinogenesis; 2006 Dec; 27(12):2455-63. PubMed ID: 16777983 [TBL] [Abstract][Full Text] [Related]
11. 1,2,3,4,6-Penta-O-galloyl-β-D-glucopyranose inhibits angiogenesis via inhibition of capillary morphogenesis gene 2. Cryan LM; Bazinet L; Habeshian KA; Cao S; Clardy J; Christensen KA; Rogers MS J Med Chem; 2013 Mar; 56(5):1940-5. PubMed ID: 23394144 [TBL] [Abstract][Full Text] [Related]
12. Involvement of autophagy induction in penta-1,2,3,4,6-O-galloyl-β-D-glucose-induced senescence-like growth arrest in human cancer cells. Dong Y; Yin S; Jiang C; Luo X; Guo X; Zhao C; Fan L; Meng Y; Lu J; Song X; Zhang X; Chen N; Hu H Autophagy; 2014 Feb; 10(2):296-310. PubMed ID: 24389959 [TBL] [Abstract][Full Text] [Related]
13. Semaphorin-3F is an inhibitor of tumor angiogenesis. Kessler O; Shraga-Heled N; Lange T; Gutmann-Raviv N; Sabo E; Baruch L; Machluf M; Neufeld G Cancer Res; 2004 Feb; 64(3):1008-15. PubMed ID: 14871832 [TBL] [Abstract][Full Text] [Related]
14. Penta-O-galloyl-β-D-glucose ameliorates inflammation by inhibiting MyD88/NF-κB and MyD88/MAPK signalling pathways. Jang SE; Hyam SR; Jeong JJ; Han MJ; Kim DH Br J Pharmacol; 2013 Nov; 170(5):1078-91. PubMed ID: 23941302 [TBL] [Abstract][Full Text] [Related]
15. Platycodin D Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Blocking the Activation of Mitogen-Activated Protein Kinases and the Production of Interleukin-8. Son JA; Lee SK; Park J; Jung MJ; An SE; Yang HJ; Son SH; Kim KR; Park KK; Chung WY Am J Chin Med; 2022; 50(6):1645-1661. PubMed ID: 35848124 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a). Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434 [TBL] [Abstract][Full Text] [Related]
17. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells. Yeh CH; Peng HC; Yang RS; Huang TF Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719 [TBL] [Abstract][Full Text] [Related]
18. Penta-O-galloyl-beta-D-glucose induces G1 arrest and DNA replicative S-phase arrest independently of cyclin-dependent kinase inhibitor 1A, cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple negative xenograft growth. Chai Y; Lee HJ; Shaik AA; Nkhata K; Xing C; Zhang J; Jeong SJ; Kim SH; Lu J Breast Cancer Res; 2010; 12(5):R67. PubMed ID: 20809980 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/Akt pathways. Jee SH; Chu CY; Chiu HC; Huang YL; Tsai WL; Liao YH; Kuo ML J Invest Dermatol; 2004 Dec; 123(6):1169-75. PubMed ID: 15610530 [TBL] [Abstract][Full Text] [Related]
20. Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. Tortora G; Caputo R; Damiano V; Melisi D; Bianco R; Fontanini G; Veneziani BM; De Placido S; Bianco AR; Ciardiello F Clin Cancer Res; 2003 Apr; 9(4):1566-72. PubMed ID: 12684433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]